Abstract: The SS31 peptide market in 2025 is driven by mitochondrial-targeted antioxidant efficacy, with robust preclinical data supporting its role in oxidative stress and aging. Product comparisons highlight variations in purity, formulation, and bioavailability. This sourcing guide offers industry insights on regulatory compliance, supplier verification, and selection criteria, enabling informed procurement for research and therapeutic development.
Target Keyword: ss31 peptide
The SS31 peptide, also known as Elamipretide or MTP-131, is a mitochondrial-targeted tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. This small molecule is engineered to selectively bind to cardiolipin, a phospholipid found exclusively in the inner mitochondrial membrane. By stabilizing this interaction, SS31 peptide enhances mitochondrial electron transport chain efficiency and reduces reactive oxygen species (ROS) production. For B2B buyers in cosmetic formulation and laboratory research, the core value lies in its potent antioxidant mechanism that targets the primary source of cellular oxidative stress, offering a distinct advantage over conventional free-radical scavengers.
Industry data from 2024 indicates that the global mitochondrial-targeted peptide market is projected to grow at a CAGR of 8.3% through 2030, with SS31 peptide accounting for over 35% of research peptide procurement in anti-aging and metabolic disorder studies.
Production of SS31 peptide follows a rigorous solid-phase peptide synthesis (SPPS) protocol, typically using Fmoc chemistry on a Rink amide resin. The process involves sequential coupling of protected amino acids, including the non-natural D-arginine and 2,6-dimethyltyrosine (Dmt), which are critical for mitochondrial targeting and stability. After cleavage and deprotection, the crude peptide undergoes preparative HPLC purification to achieve the desired purity threshold. Quality control is paramount, with each batch subjected to multiple analytical methods to ensure consistency and safety for downstream applications.
SS31 peptide serves as a versatile raw material across multiple B2B sectors, from cosmetic ingredient suppliers to contract research organizations. In cosmetic formulation, it is incorporated into anti-aging serums and creams at concentrations of 0.1–1.0%, targeting mitochondrial dysfunction in skin cells to reduce fine lines and improve dermal elasticity. For laboratory research, SS31 peptide is used in cell culture models of oxidative stress, ischemia-reperfusion injury, and neurodegenerative diseases, typically at doses ranging from 1–100 µM. Bulk wholesale buyers, such as peptide libraries and biotech firms, procure SS31 peptide in gram-to-kilogram quantities for preclinical toxicology studies and formulation development.
| Item | Our Product (SS31 Peptide) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity Level | ≥98% (HPLC), with detailed CoA | Often <90%, with unknown impurities | Higher efficacy and reduced batch variability |
| Mitochondrial Targeting | Specific cardiolipin binding | Non-targeted, general antioxidant | Direct action at ROS source |
| Stability | D-amino acids enhance half-life | L-amino acids degrade rapidly | Longer shelf life and in vivo activity |
| Bioavailability | High membrane permeability | Poor cellular uptake | Lower effective dose required |
| Regulatory Compliance | Full documentation for research use | Often lacks traceability | Supports reproducible science |
When sourcing SS31 peptide for commercial or research purposes, buyers must navigate common pitfalls such as mislabeled purity, inadequate storage conditions, and lack of third-party verification. A systematic approach to supplier evaluation ensures that the procured material meets the required specifications for downstream applications. The following checklist outlines critical selection standards for bulk procurement.
The SS31 peptide offered by our platform is distinguished by three key attributes: exceptional purity, proven stability, and cost-effective pricing backed by technical support. Each batch is synthesized using optimized SPPS protocols and purified to ≥98% with full analytical documentation, ensuring reproducibility in research and formulation. The inclusion of D-amino acids and Dmt residue provides superior resistance to proteolysis, extending the peptide's active window in biological systems. For bulk buyers, our tiered pricing model offers significant savings without compromising quality, and our technical team provides formulation guidance and stability data to facilitate seamless integration into your workflows.
Q1: What is the recommended storage condition for SS31 peptide to maintain its stability?
A: SS31 peptide should be stored as a lyophilized powder at -20°C, protected from moisture and light. Under these conditions, it remains stable for up to 24 months. Once reconstituted in sterile water or PBS, it should be used within 72 hours if kept at 4°C, or aliquoted and frozen at -20°C for longer storage, avoiding repeated freeze-thaw cycles.
Q2: How does SS31 peptide differ from other mitochondrial-targeted antioxidants like MitoQ?
A: While both target mitochondria, SS31 peptide binds specifically to cardiolipin to stabilize the electron transport chain, reducing ROS production at the source. MitoQ, in contrast, is a ubiquinone derivative that accumulates in mitochondria via a triphenylphosphonium cation. SS31 peptide's mechanism is more direct in terms of mitochondrial membrane stabilization, and its peptide structure allows for easier formulation in aqueous solutions.
Q3: What purity level is required for SS31 peptide used in cosmetic formulations versus laboratory research?
A: For cosmetic formulations, a purity of ≥98% is standard to ensure product safety and efficacy, with endotoxin levels controlled. For laboratory research, especially in cell-based assays, ≥99% purity is recommended to minimize confounding effects from impurities. Always request a certificate of analysis from the supplier to confirm the purity and batch-specific data.